Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination
Clinical trial NCT01650389 · COMPLETED
Trial details
- NCT number
- NCT01650389
- Sponsor
- Mark Hatherill
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2015-05-01
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.